BioNotebook: Calico, Anthera, Vical, Topokine, Cardiome
This article was originally published in Scrip
Executive Summary
Google's Calico makes high-profile hires; Anthera's Phase III varespladib failure details; Vical data highlight Phase III Allovectin failure; Phase II start for Topokine's topical chin fat reducer; and Cardiome buys Correvio.